Literature DB >> 4617744

Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy.

N Callagham, M Mcllroy, M O'Connor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4617744     DOI: 10.1007/bf03004743

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  16 in total

Review 1.  Drug therapy of parkinsonism.

Authors:  M D Yahr; R C Duvoisin
Journal:  N Engl J Med       Date:  1972-07-06       Impact factor: 91.245

2.  Combined treatment of parkinsonism with L-dopa and amantadine.

Authors:  K R Hunter; G M Stern; D R Laurence; P Armitage
Journal:  Lancet       Date:  1970-09-12       Impact factor: 79.321

3.  Combined treatment of Parkinson's disease with amantadine and L-dopa.

Authors:  G Scotti
Journal:  Lancet       Date:  1970-06-27       Impact factor: 79.321

4.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

5.  Controlled trial of amantadine hydrochloride in Parkinson's disease.

Authors:  J D Parkes; D M Calver; K J Zilkha; R P Knill-Jones
Journal:  Lancet       Date:  1970-02-07       Impact factor: 79.321

6.  Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.

Authors:  R S Schwab; A C England
Journal:  Trans Am Neurol Assoc       Date:  1969

7.  [The treatment of parkinsonism with amantadine].

Authors:  G W Völler
Journal:  Dtsch Med Wochenschr       Date:  1970-04-24       Impact factor: 0.628

8.  Amantadine in the treatment of Parkinson's disease.

Authors:  R S Schwab; A C England; D C Poskanzer; R R Young
Journal:  JAMA       Date:  1969-05-19       Impact factor: 56.272

9.  L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.

Authors:  M D Yahr; R C Duvoisin; M M Hoehn; M J Schear; R E Barrett
Journal:  Trans Am Neurol Assoc       Date:  1968

10.  Treatment of Parkinsonism with Laevo-dopa.

Authors:  C Mawdsley
Journal:  Br Med J       Date:  1970-02-07
View more
  2 in total

1.  An extended clinical trial to compare levodopa and amantadine used as single drugs with both drugs used incombination in Parkinson's Disease.

Authors:  N Calaghan; M McIlroy; M O'Connor
Journal:  Ir J Med Sci       Date:  1974-03       Impact factor: 1.568

Review 2.  Amantadine in Parkinson's disease.

Authors:  N Crosby; K H Deane; C E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.